[Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)]
[Notices]
[Pages 19787-19788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10546]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Research and Development Cooperative Studies Evaluation
Committee; Notice of Meeting
The Department of Veterans Affairs gives notice under Public Law
92-463 (Federal Advisory Committee Act) as amended, by section 5(c) of
Public Law 94-409, that a meeting of the Research and Development
Cooperative Studies Evaluation Committee will be held at the Marriott
Residence Inn, 500 Army Navy Drive, Arlington, VA 22202, on May 4-5,
1998. The session on May 4 is scheduled to begin at 7:30 a.m. and end
at 5:30 p.m. and on May 5 from 7:30 a.m. to 5:15 p.m. The meeting will
be for the purpose of reviewing the following seven new proposals:
therapy for hepatitis C related cirrhosis, prophylaxis of medical
patients for thromboembolism, telemedicine on diabetic retinopathy,
iron and atheroclerosis, influenza vaccine for COPD patients, therapy
for heart failure patients, and hernia repair. The Committee will also
review the progress of one ongoing study of treatment for liver
fibrosis.
The Committee advises the Chief Research and Development Officer
through the Chief of the Cooperative Studies Program on the relevance
and feasibility of the studies, the adequacy of the protocols, and the
scientific validity and propriety of technical details, including
protection of human subjects.
The meeting will be open to the public from 7:30 a.m. to 8:00 a.m.
on both days to discuss the general status of the program. Those who
plan to attend should contact Dr. Ping Huang, Coordinator, Research and
Development Cooperative Studies Evaluation Committee, Department of
Veterans Affairs, 810 Vermont Avenue, NW, Washington, DC, (202-273-
8295), prior to April 30, 1998.
[[Page 19788]]
The meeting will be closed from 8:00 a.m. to 5:30 p.m. on May 4,
1998, and from 8:00 a.m. to 5:15 p.m., on May 5, 1998. These portions
of the meeting involve consideration of specific proposals in
accordance with provisions set forth in section 10(d) of Public Law 92-
463, as amended by section 5(c) of Public Law 92-409, and 5 U.S.C.
552b(c)(6). During the closed sessions of the meeting, discussions and
recommendations will deal with qualifications of personnel conducting
the studies, staff and consultant critiques of research protocols, and
similar documents, and the medical records of patients who are study
subjects, the disclosures of which would constitute a clearly
unwarranted invasion of personal privacy.
Dated: April 14, 1998.
By Direction of the Acting Secretary.
Heyward Bannister,
Committee Management Officer.
[FR Doc. 98-10546 Filed 4-20-98; 8:45 am]
BILLING CODE 8320-01-M
